A new indication for liver transplantation: Nodular regenerative hyperplasia in human immunodeficiency virus–infected patients | Zendy

Tateo Mariagrazia | Zendy; Sebagh Mylène | Zendy; Bralet MariePierre | Zendy; Teicher Elina | Zendy; Azoulay Daniel | Zendy; Mallet Vincent | Zendy; Pol Stanislas | Zendy; Castaing Denis | Zendy; Samuel Didier | Zendy; DuclosVallée JeanCharles | Zendy

Premium

A new indication for liver transplantation: Nodular regenerative hyperplasia in human immunodeficiency virus–infected patients

Author(s) -

Tateo Mariagrazia,

Sebagh Mylène,

Bralet MariePierre,

Teicher Elina,

Azoulay Daniel,

Mallet Vincent,

Pol Stanislas,

Castaing Denis,

Samuel Didier,

DuclosVallée JeanCharles

Publication year - 2008

Publication title -

liver transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.814

H-Index - 150

eISSN - 1527-6473

pISSN - 1527-6465

DOI - 10.1002/lt.21493

Subject(s) - medicine , liver transplantation , nodular regenerative hyperplasia , human immunodeficiency virus (hiv) , transplantation , hyperplasia , virology , immunodeficiency , pathology , immunology , gastroenterology , cirrhosis , portal hypertension , immune system

Nodular regenerative hyperplasia is one of the causes of noncirrhotic portal hypertension and has recently been described in human immunodeficiency virus–infected patients, and the potential role of a prothrombotic state and hepatotoxic antiretroviral medication has been suggested. Moreover, it is now established that liver transplantation is feasible in HIV‐infected patients. We describe here our experience concerning 3 HIV‐infected patients with severe complications of nodular regenerative hyperplasia treated with liver transplantation. Liver Transpl 14:1194–1198, 2008. © 2008 AASLD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research